Home › Funds › Prosight Management, LP › ZYME
Prosight Management, LP position in ZYME
ZYMEWORKS INC · Health Care
Prosight Management, LP reported holding 721,100 shares of ZYME (ZYMEWORKS INC) in its Q3 2026 13F filing — a position valued at US$19.1M, representing 3.71% of its reported portfolio and ranking #12 among its reported holdings. Prosight Management, LP has disclosed ZYME holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Prosight Management, LP's ZYME position evolved
Prosight Management, LP first disclosed a stake in ZYME in Q3 2023 at 106,405 shares (US$675K). The position peaked in Q3 2026 at 721,100 shares, worth US$19.1M. Across 12 filings, Prosight Management, LP increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 721,100 shares valued at US$19.1M — an increase of 46,666 shares quarter over quarter.. Notable position changes include a 187% increase in Q2 2024 (shares rose 47% over the following quarter), a 37% increase in Q2 2025 (shares rose 36% over the following quarter), a 43% trim in Q3 2025 (shares rose 54% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 106.41K | $674.61K | New |
| Q1 2024 | 410.95K | $4.32M | New |
| Q2 2024 | 1.18M | $10.04M | Add |
| Q3 2024 | 917.60K | $11.52M | Reduce |
| Q4 2024 | 820.00K | $12.00M | Reduce |
| Q1 2025 | 957.23K | $11.40M | Add |
| Q2 2025 | 1.31M | $16.44M | Add |
| Q3 2025 | 749.61K | $12.80M | Reduce |
| Q4 2025 | 530.39K | $13.97M | Reduce |
| Q1 2026 | 539.05K | $13.50M | Add |
| Q2 2026 | 674.43K | $17.63M | Add |
| Q3 2026 | 721.10K | $19.10M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZYME and 13F data
ZYME (ZYMEWORKS INC) is a Health Care company. 25 other funds we track also report a position in ZYME — the largest reported positions include EcoR1 Capital, LLC (US$600.4M), Rubric Capital Management LP (US$183.0M), PERCEPTIVE ADVISORS LLC (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZYME
- EcoR1 Capital, LLC 22.97M sh · $600.45M · Q2 2026
- Rubric Capital Management LP 7.00M sh · $182.98M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.18M sh · $109.34M · Q2 2026
- BVF INC/IL 3.65M sh · $95.39M · Q2 2026
- Nextech Invest Ltd. 1.11M sh · $29.12M · Q2 2026
- Redmile Group, LLC 491.65K sh · $12.85M · Q2 2026
More on Prosight Management, LP
FAQ
How long has Prosight Management, LP held ZYME?
Prosight Management, LP has disclosed ZYME holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
What is Prosight Management, LP's current position in ZYME?
As of Q3 2026, Prosight Management, LP holds 721.10K shares of ZYME (ZYMEWORKS INC), valued at $19.10M, representing 3.71% of its reported portfolio and ranking #12.
Has Prosight Management, LP been buying or selling ZYME?
In the latest 13F filing (Q3 2026), Prosight Management, LP increased its position in ZYME. The position peaked in Q3 2026 at 721.10K shares.
Which other funds hold ZYME?
Other major institutional holders of ZYME include EcoR1 Capital, LLC, Rubric Capital Management LP, PERCEPTIVE ADVISORS LLC, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.